Concepedia

Allyn T. Londregan

AT

30

Publications

1.5K

Citations

22

H-Index

2006

Active since

Affiliations

Pfizer (United States)(Current)

University of Pennsylvania

University of Mississippi

University of California, Berkeley

Lawrence Berkeley National Laboratory

Allyn T. Londregan is an author at Pfizer (United States) specializing in medicine, natural sciences, and pharmacology.

ORCID

Top concepts

Publications per year

2006–2022

30

Publications

30

Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms

Matthew F. Calabrese, Francis Rajamohan, Melissa S. Harris et al. · Structure · 2014 · 179 citations · Full text

, , +9

General and Mild Preparation of 2-Aminopyridines

Allyn T. Londregan, Sandra M. Jennings, Liuqing Wei · Organic Letters · 2010 · 157 citations

Mild Addition of Nucleophiles to Pyridine-<i>N</i>-Oxides

Allyn T. Londregan, Sandra M. Jennings, Liuqing Wei · Organic Letters · 2011 · 127 citations

Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain

Nathanael G. Lintner, Kim F. McClure, Donna N. Petersen et al. · PLoS Biology · 2017 · 125 citations · Full text

, , +20

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate

Samit K. Bhattacharya, Kim Andrews, Ramsay E. Beveridge et al. · ACS Medicinal Chemistry Letters · 2014 · 67 citations · Full text

, , +10

Rows per page

1–5 of 30